HLA Class I Rabbit Polyclonal Antibody
To Order Contact us: [email protected]
HLA Class I Polyclonal Antibody |
|||
ES8555-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against HLA Class I from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
HLA Class I Polyclonal Antibody |
|||
ES8555-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against HLA Class I from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
HLA Class I Antibody |
|||
DF2939 | Affbiotech | 200ul | EUR 420 |
HLA Class I Antibody |
|||
DF13389 | Affbiotech | 100ul | EUR 420 |
HLA Class I Antibody |
|||
DF8558 | Affbiotech | 200ul | EUR 420 |
HLA Class I Antibody |
|||
45353-100ul | SAB | 100ul | EUR 302.4 |
HLA Class I Antibody |
|||
45353-50ul | SAB | 50ul | EUR 224.4 |
HLA-Class I Antibody |
|||
abx139485-01mg | Abbexa | 0.1 mg | EUR 493.2 |
HLA-Class I Antibody |
|||
abx139486-01mg | Abbexa | 0.1 mg | EUR 493.2 |
HLA-Class I Antibody |
|||
abx139487-01mg | Abbexa | 0.1 mg | EUR 427.2 |
HLA-Class I Antibody |
|||
abx139488-01mg | Abbexa | 0.1 mg | EUR 444 |
HLA-Class I Antibody |
|||
abx139489-01mg | Abbexa | 0.1 mg | EUR 444 |
HLA Class I Antibody |
|||
ABD8558 | Lifescience Market | 100 ug | EUR 525.6 |
HLA class I (HLA-A) Antibody |
|||
abx233895-100ug | Abbexa | 100 ug | EUR 661.2 |
HLA class I (HLA-A) Antibody |
|||
abx233896-100ug | Abbexa | 100 ug | EUR 661.2 |
HLA class I (HLA-B) Antibody |
|||
abx233897-100ug | Abbexa | 100 ug | EUR 661.2 |
HLA class I (HLA-C) Antibody |
|||
abx233898-100ug | Abbexa | 100 ug | EUR 661.2 |
HLA Class I Conjugated Antibody |
|||
C45353 | SAB | 100ul | EUR 476.4 |
HLA MHC Class I antibody |
|||
10R-6691 | Fitzgerald | 100 ug | EUR 379.2 |
Description: Mouse monoclonal HLA MHC Class I antibody |
HLA-Class I Antibody (PE) |
|||
abx139490-01mg | Abbexa | 0.1 mg | EUR 644.4 |
HLA-Class I Antibody (PE) |
|||
abx139491-01mg | Abbexa | 0.1 mg | EUR 644.4 |
HLA-Class I Antibody (PE) |
|||
abx139492-01mg | Abbexa | 0.1 mg | EUR 744 |
HLA-Class I Antibody (Biotin) |
|||
abx139493-01mg | Abbexa | 0.1 mg | EUR 644.4 |
HLA-Class I Antibody (FITC) |
|||
abx139494-01mg | Abbexa | 0.1 mg | EUR 644.4 |
Anti-HLA-Class I antibody |
|||
STJ16100127 | St John's Laboratory | 100 µg | EUR 573.6 |
Anti-HLA-Class I antibody |
|||
STJ16100128 | St John's Laboratory | 100 µg | EUR 738 |
Anti-HLA-Class I antibody |
|||
STJ16100129 | St John's Laboratory | 100 µg | EUR 738 |
Anti-HLA-Class I antibody |
|||
STJ16100130 | St John's Laboratory | 100 µg | EUR 738 |
Anti-HLA-Class I antibody |
|||
STJ16100202 | St John's Laboratory | 100 µg | EUR 483.6 |
Anti-HLA-Class I antibody |
|||
STJ16100203 | St John's Laboratory | 100 µg | EUR 483.6 |
Anti-HLA Class I antibody |
|||
STJ98596 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to HLA Class I. |
Anti-HLA Class I antibody |
|||
STJ98668 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to HLA Class I. |
anti- HLA class I(HLA-A) antibody |
|||
FNab03895 | FN Test | 100µg | EUR 702 |
Description: Antibody raised against HLA class I(HLA-A) |
anti- HLA class I(HLA-A) antibody |
|||
FNab03896 | FN Test | 100µg | EUR 702 |
Description: Antibody raised against HLA class I(HLA-A) |
anti- HLA class I(HLA-B) antibody |
|||
FNab03897 | FN Test | 100µg | EUR 702 |
Description: Antibody raised against HLA class I(HLA-B) |
anti- HLA class I(HLA-C) antibody |
|||
FNab03898 | FN Test | 100µg | EUR 702 |
Description: Antibody raised against HLA class I(HLA-C) |
Anti-HLA class I (HLA-A) antibody |
|||
PAab03895 | Lifescience Market | 100 ug | EUR 494.4 |
Anti-HLA class I (HLA-B) antibody |
|||
PAab03897 | Lifescience Market | 100 ug | EUR 494.4 |
Anti-HLA class I (HLA-C) antibody |
|||
PAab03898 | Lifescience Market | 100 ug | EUR 494.4 |
HLA Class I Histocompatibility Antigen, A-68 Alpha Chain (HLA Class I) Antibody |
|||
20-abx215936 | Abbexa |
|
|
HLA-B Antibody (MHC Class I) |
|||
F54291-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
HLA-B Antibody (MHC Class I) |
|||
F54291-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
HLA-B Antibody (MHC Class I) |
|||
V2575-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
HLA-B Antibody (MHC Class I) |
|||
V2575-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
HLA-B Antibody (MHC Class I) |
|||
V2575SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
HLA-B Antibody (MHC Class I) |
|||
V2577-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes the HLA-B27 cell surface antigen on human cells. It may be used to HLA type human lymphocytes. Approximately 60% of patients with ankylosing spondylitis are HLA-B27 positive. This reagent can be used to help identify this HLA haplotype in human lymphocytes. Major histocompatibility complex (MHC) molecules form an integral part of the immune response system. They are cell-surface receptors that bind pep- tides and present them to T lymphocytes. Human leukocyte antigens (HLAs) are polymorphic members of the MHC family that are specifically involved in the presentation of antigens to the T cell receptor. There are two classes of HLA antigens: class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). Class I molecules are expressed in nearly all cells and play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum. The differential structural properties of MHC class I and class II molecules account for their respective roles in activating different populations of T lymphocytes. HLA-B encodes a membrane anchored heavy chain, which hetero-dimerizes with a light chain (b-2-Microglobulin) to form MHC-I. Polymorphisms yield hundreds of HLA-B alleles. The HLA-B27 allele appears with increased frequency in uveitis patients. |
HLA-B Antibody (MHC Class I) |
|||
V2577-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb recognizes the HLA-B27 cell surface antigen on human cells. It may be used to HLA type human lymphocytes. Approximately 60% of patients with ankylosing spondylitis are HLA-B27 positive. This reagent can be used to help identify this HLA haplotype in human lymphocytes. Major histocompatibility complex (MHC) molecules form an integral part of the immune response system. They are cell-surface receptors that bind pep- tides and present them to T lymphocytes. Human leukocyte antigens (HLAs) are polymorphic members of the MHC family that are specifically involved in the presentation of antigens to the T cell receptor. There are two classes of HLA antigens: class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). Class I molecules are expressed in nearly all cells and play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum. The differential structural properties of MHC class I and class II molecules account for their respective roles in activating different populations of T lymphocytes. HLA-B encodes a membrane anchored heavy chain, which hetero-dimerizes with a light chain (b-2-Microglobulin) to form MHC-I. Polymorphisms yield hundreds of HLA-B alleles. The HLA-B27 allele appears with increased frequency in uveitis patients. |
HLA-B Antibody (MHC Class I) |
|||
V2577SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes the HLA-B27 cell surface antigen on human cells. It may be used to HLA type human lymphocytes. Approximately 60% of patients with ankylosing spondylitis are HLA-B27 positive. This reagent can be used to help identify this HLA haplotype in human lymphocytes. Major histocompatibility complex (MHC) molecules form an integral part of the immune response system. They are cell-surface receptors that bind pep- tides and present them to T lymphocytes. Human leukocyte antigens (HLAs) are polymorphic members of the MHC family that are specifically involved in the presentation of antigens to the T cell receptor. There are two classes of HLA antigens: class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). Class I molecules are expressed in nearly all cells and play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum. The differential structural properties of MHC class I and class II molecules account for their respective roles in activating different populations of T lymphocytes. HLA-B encodes a membrane anchored heavy chain, which hetero-dimerizes with a light chain (b-2-Microglobulin) to form MHC-I. Polymorphisms yield hundreds of HLA-B alleles. The HLA-B27 allele appears with increased frequency in uveitis patients. |
HLA-B Antibody (MHC Class I) |
|||
V8848-100UG | NSJ Bioreagents | 100ug | EUR 499 |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
HLA-B Antibody (MHC Class I) |
|||
V8848-20UG | NSJ Bioreagents | 20ug | EUR 219 |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
HLA-B Antibody (MHC Class I) |
|||
V8848SAF-100UG | NSJ Bioreagents | 100ug | EUR 499 |
Description: HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. |
HLA Class I Blocking Peptide |
|||
DF8558-BP | Affbiotech | 1mg | EUR 234 |
Anti-HLA Class I PE |
|||
1P-242-C025 | ExBio | 0.025 mg | EUR 189.6 |
Anti-HLA Class I PE |
|||
1P-242-C100 | ExBio | 0.1 mg | EUR 332.4 |
Anti-HLA Class I PE |
|||
1P-363-C025 | ExBio | 0.025 mg | EUR 189.6 |
Anti-HLA Class I PE |
|||
1P-363-C100 | ExBio | 0.1 mg | EUR 332.4 |
Anti-HLA Class I PE |
|||
1P-422-C025 | ExBio | 0.025 mg | EUR 223.2 |
Anti-HLA Class I PE |
|||
1P-422-C100 | ExBio | 0.1 mg | EUR 397.2 |
Anti-HLA Class I Purified |
|||
11-242-C025 | ExBio | 0.025 mg | EUR 124.8 |
Anti-HLA Class I Purified |
|||
11-242-C100 | ExBio | 0.1 mg | EUR 200.4 |
Anti-HLA Class I Purified |
|||
11-243-C025 | ExBio | 0.025 mg | EUR 118.8 |
Anti-HLA Class I Purified |
|||
11-243-C100 | ExBio | 0.1 mg | EUR 189.6 |
Anti-HLA Class I Purified |
|||
11-363-C025 | ExBio | 0.025 mg | EUR 124.8 |
Anti-HLA Class I Purified |
|||
11-363-C100 | ExBio | 0.1 mg | EUR 200.4 |